Chemists have demonstrated a new approach to blocking cancer-drug resistance that they believe could be applied to any type of cancer. In a dramatic result, the approach -- which involves chemically combining two existing drugs in a new way -- produced 50 percent smaller tumors in mice compared with a traditional treatment with the same drugs given separately.